Xavier Valdez analyses the dynamics impacting the Mexican pharmaceutical market and explains why IMS Health is transforming itself to strengthen its position as the partner of choice for decision-makers throughout the entire value chain.
How would you assess the performance of the Mexican pharmaceutical market for 2015?
From 2014 to 2015, the total Mexican pharmaceutical market displayed a strong 5.3 percent growth to reach 209.5 billion Mexican pesos [USD 11.14 billion]. Interestingly, the private retail market grew 7.1 percent over the past 12 months, whereas it had dropped 0.2 percent in 2014. This return to robust growth of the private sector is now propelling the overall market, as the retail market still represents 74 percent of the total Mexican sales.
Domestic companies still take the lion’s share of the current growth of the retail market, and display the most impressive sales increase among all companies operating in this sector.
